In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

InnoPharm Ltd.

Division of Pharmaceutical Product Development Inc.
www.innopharm.ru

Latest From InnoPharm Ltd.

Crowdfunder Poliwogg Aims To Tap Broad Investor Base For Start-Ups

The JOBS Act allows young companies to make their pitch openly to hundreds of thousands of wealthy individuals who rarely invest in private life sciences companies. Can Poliwogg’s new web site connect them, and bridge the funding gap between foundations and VCs?

United States Business Strategies

Crowdfunder Poliwogg Launches Web Site, With Deals & New Advisor

The New York-based company has new relationships with a pair of disease foundations and a veteran venture investor. Its Web platform is designed to connect micro-investors with projects of interest, in a fashion enabled by new provisions of the JOBS Act.

United States Business Strategies

People Power: How The Crowd May Shape The Funding And Development Of Drugs

Companies are sprouting across the pharma value chain that harness the voices of patients and other individual stakeholders to drive the research, development, and financing of drugs. Pharma is taking tentative steps toward using these methods, but high barriers remain to their systematic integration in R&D.

BioPharmaceutical Innovation

Armed With An FDA-Cleared IND, TLS Sets Out To Democratize Clinical Trials

Transparency Life Sciences applies crowdsourcing to the design of clinical protocols with the aim of lowering costs and improving outcomes for clinical trials. The company won FDA clearance for its first IND based on a protocol that resulted from its process and is securing its first financing.

BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Eastern Europe
        • Russia
  • Parent & Subsidiaries
  • Pharmaceutical Product Development Inc.
  • Senior Management
  • Vladimir Krechikov, Mgr., Bus. Dev.
  • Contact Info
  • InnoPharm Ltd.
    Phone: (7) 4812 31 5335
    P.O. Box 57 Smolensk, 214019
    Russia
UsernamePublicRestriction

Register